Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Time Is Right to Join RheumPAC

James Engelbrecht, MD  |  Issue: December 2013  |  December 1, 2013

Dr. Engelbrecht
Dr. Engelbrecht

When a few hundred rheumatologists raise their voices on a Medicare issue, for a while it may seem like a cry in the wilderness. When a few hundred rheumatologists enlist the support of a few hundred thousand of their patients, families, and friends on a Medicare issue, the message is suddenly on the Congressional radar in a big way. However, what happens next is the critical part.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Consider the discussion between a member of Congress and staff: “We’re getting all these calls and e-mails about some arthritis drug and Medicare. What’s this arthritis issue all about? Can we get more information? Weren’t those arthritis people, you know, the ones who gave us those bent-up fork lapel pins? They were just here a few weeks ago. Wasn’t Dr. Smith, who attended our last fundraiser, a rheumatologist? Do we have his card? Get his information from our files and call him. Here’s a card from their legislative guy, Adam Cooper. Let’s put a call in to him as well.” It is at that point, when they call us, that we as an organization know political success.

Many have the misconception that RheumPAC’s mission is to simply distribute funds to campaigns of those who might vote our way. In reality, the most important thing that RheumPAC does is open doors and establishes relationships with key members of Congress so that when we can get an issue on their radar, they actually look to us for trustworthy and reliable information. Our recent experience with the Medicare carriers and the self-administered drug (SAD) list (see “ACR Helps Keep Three Biologics Off the SAD List” at www.The-Rheumatologist.org for more information) and the movement toward resolving the issue is evidence that we have relationships in place that can effect immediate administrative change. A few phone calls from a congressional office to a Medicare carrier can result in some sudden changes. Our relationship building is an ongoing, improving, growing, dynamic process that amplifies our voices and elicits response. We can expect results like the change in this most recent egregious Medicare Administrative Contractor policy.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Amazingly, RheumPAC has done this with less than 3%—yes, 3%—of our membership’s support. Imagine what we could do with 10, 20, or 30%! Your RheumPAC committee, in existence now for six years, has begged, badgered, and bugged our members for support in every conceivable manner. Every single dollar of these contributions has been used to open doors and build relationships with key congressional leaders. We are not Republicans or Democrats, liberals or conservatives, but we are in the Rheumatology Party. We seek out key members of Congress that we can work with on rheumatology issues.

Page: 1 2 | Single Page
Share: 

Filed under:From the CollegeLegislation & Advocacy Tagged with:AC&RAdvocacyrheumatologyRheumPAC

Related Articles

    PAC Progress and Challenges

    November 1, 2009

    After three years, RheumPAC has a solid start, and more work ahead of it

    I RheumPAC, Do You?

    September 1, 2009

    For many years, the ACR board of directors and Government Affairs Committee have done exemplary work in keeping members abreast of legislative regulatory issues that affect all aspects of rheumatology, including patient and physician/healthcare professional issues, education, and research. Through advocacy, the ACR advances rheumatology and fosters excellence in the care of people with, or at risk for, arthritis and rheumatic and musculoskeletal diseases. One might say that advocacy is a cornerstone of this organization.

    A Huge Thank You to 251 People

    March 18, 2011

    RheumPAC supporters are helping to advance rheumatology

    Advancing the ACR’s Legislative Priorities in 2021

    January 11, 2021

    With a new Congress and many new legislators in key leadership positions, your support today will help RheumPAC start the year off strong.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences